Watch CBS News

Drug company set to lower cost of Daraprim after backlash

The CEO of Turing Pharmaceuticals says that the company will lower the cost of Daraprim after a backlashed caused by a sudden 5000% increase in the price of the drug used to treat cancer and AIDS patients. Don Dahler has the latest.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.